Clinical trial
Pharmacokinetics of Patupilone After a Single Intravenous Administration in…
NCT00426140 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00426140 |
|---|---|
| Title | Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies. |
| Official title | An Open-label Single Center Study to Characterize the Absorption, Distribution, Metabolism, and Elimination (ADME) of Patupilone (EPO906) After a Single Intravenous Administration of 10 mg/m2 [14C] Patupilone in Patients With Advanced Solid Tumor Malignancies. |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Advanced Malignancies, Solid Tumors |
| Intervention type | Drug |
| Interventions | Patupilone |
| Enrollment | 5 |
| Start date | Aug 1, 2006 |
| Primary completion | Nov 1, 2006 |
| First posted | Jan 24, 2007 |
| Last update posted | Dec 8, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: